Immunicom
Michael Lehman is a financial and operating executive with extensive experience as CFO and COO for high-growth technology companies. He has had direct corporate management of key operating functions, including finance, legal, human resources, information technology, manufacturing operations and supply chain, facilities/real estate, and corporate strategy/development and planning. After starting his career at Price Waterhouse, he joined Sun Microsystems, where he eventually held the position of CFO for 13 years over two stints at the company. He then lent his experience as CFO to two pre-IPO companies, Palo Alto Networks and Arista Networks, successfully executing operating plans to develop and scale their systems and processes to support subsequent IPOs. In the last five years, he has served his alma mater, the University of Wisconsin-Madison, in the role of special advisor to the Chancellor, stepping in to fill key operating roles, including Chief Information Officer, on an interim basis for the University. Mr. Lehman has held an interim CEO position for a pre-IPO company, and he is well-known for identifying, developing, and mentoring executives, ranging from CFOs and General Counsels to CIOs and HR VPs. He has been on the board of numerous public and private companies, and is currently
lead independent director and chair of the Management Development, Nominating and Governance Committee for an NYSE listed company, and Audit Committee chair for a NASDAQ listed company.
This person is not in the org chart
This person is not in any offices
Immunicom
Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.